Abstract: A shed form of leukocyte adhesion molecule-1 (LAM-1, L-selectin) is present in high levels in human plasma. Quantitative methods of detecting shed LAM-1 (sLAM-1) by Western blot and ELISA analysis are disclosed. Also disclosed are methods for the specific detection of cell-surface bound LAM-1 in the presence of shed LAM-1 and for immunotherapy using monoclonal antibodies reactive with cell-surface bound LAM-1 but not reactive with shed LAM-1.
Type:
Grant
Filed:
April 2, 1992
Date of Patent:
February 14, 1995
Assignee:
Dana-Farber Cancer Institute, Inc.
Inventors:
Thomas F. Tedder, Boris Schleiffenbaum, Olivier Spertini